Reyataz
Product Images NDC 69189-3631

3 FDA label images from Avera Mckennan Hospital · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Reyataz (NDC 69189-3631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atazanavir Sulfate 200 mg Capsule (6918936311)

Atazanavir Sulfate 200 mg Capsule (6918936311)
A small white product label displaying Atazanavir (REYATAZ) 200 mg. The label includes an NDC code partially visible as 69189-36311, the text 'BRISTOL-MEYERS', and an expiration date of 8/3/16. There is also a small QR or matrix barcode on the label. The label is affixed on a translucent plastic surface with rectangular indentations.*
FDA Label Image

Reyataz Chemical Structure (Image 01)

Reyataz Chemical Structure (Image 01)
Chemical structure diagram of the active ingredient in REYATAZ, depicting its molecular arrangement with labeled functional groups and atoms, including an associated sulfuric acid (H2SO4) molecule.*
FDA Label Image

Reyataz Fig 1 (Reyataz Figure1)

Reyataz Fig 1 (Reyataz Figure1)
Pharmacokinetic curve depicting atazanavir plasma concentration (ng/mL) over 24 hours. The graph compares two dosing regimens: ATV 400 mg and ATV/RTV 300/100 mg, showing median concentration levels with error bars and sample sizes noted. The median wild-type EC90 value of 14 ng/mL is indicated for reference.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.